Antiretroviral Therapy Current Drugs

被引：154

作者：

Pau, Alice K. ^{[1
]}

George, Jomy M. ^{[2
]}

机构：

[1] NIAID, Div Clin Res, NIH, Bethesda, MD 20892 USA

[2] Univ Sci Philadelphia, Philadelphia Coll Pharm, Dept Pharm Practice & Adm, Philadelphia, PA 19104 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2014年 / 28卷 / 03期

关键词：

HIV; Antiretroviral therapy; Nucleoside/nucleotide reverse transcriptase inhibitors; Non-nucleoside reverse transcriptase inhibitors; Protease inhibitors; Integrase strand transfer inhibitors; Fusion inhibitor; CCR5; antagonist; HIV-INFECTED PATIENTS; RITONAVIR-BOOSTED ATAZANAVIR; MYOCARDIAL-INFARCTION; RALTEGRAVIR; EFAVIRENZ; HYPERSENSITIVITY; EFFICACY; ABACAVIR; AIDS; OSTEOMALACIA;

D O I：

10.1016/j.idc.2014.06.001

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The rapid advances in drug discovery and the development of antiretroviral therapy is unprecedented in the history of modern medicine. The administration of chronic combination antiretroviral therapy targeting different stages of the human immunodeficiency virus' replicative life cycle allows for durable and maximal suppression of plasma viremia. This suppression has resulted in dramatic improvement of patient survival. This article reviews the history of antiretroviral drug development and discusses the clinical pharmacology, efficacy, and toxicities of the antiretroviral agents most commonly used in clinical practice to date.

引用

页码：371 / +

页数：33

共 50 条

[21] Antiretroviral drugs
De Clercq, Erik
[J]. CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (05) : 507 - 515
[22] Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs
Marks, D. J. B.
Dheda, K.
Dawson, R.
Ainslie, G.
Miller, R. F.
[J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2009, 20 (05) : 339 - 345
[23] Antiretroviral drugs
Roca, B
Simon, E
[J]. MEDICINA CLINICA, 1997, 109 (02): : 62 - 67
[24] Antiretroviral therapy 2010 update: Current practices and controversies
Grant, Matthew
Samuel, Rafik
Bettiker, Robert L.
Suh, Byungse
[J]. ARCHIVES OF PHARMACAL RESEARCH, 2011, 34 (07) : 1045 - 1053
[25] ANTIEPILEPTIC DRUGS AND ANTIRETROVIRAL THERAPY USE IN HIV POSITIVE PATIENTS
Magnerou, A. M.
Ngoungoure, H. F. S.
Belarabi, L.
Ndiaye, M. M.
[J]. EPILEPSIA, 2017, 58 : S158 - S158
[26] Adherence to antiretroviral therapy: an update of current concepts.
Lucas G.M.
Wu A.W.
Cheever L.W.
[J]. Current HIV/AIDS Reports, 2004, 1 (4) : 172 - 180
[27] Antiretroviral therapy 2010 update: Current practices and controversies
Matthew Grant
Rafik Samuel
Robert L. Bettiker
Byungse Suh
[J]. Archives of Pharmacal Research, 2011, 34 : 1045 - 1053
[28] Where does doravirine fit in current antiretroviral therapy?
Sinxadi, Phumla
Maartens, Gary
[J]. LANCET HIV, 2024, 11 (09): : e568 - e569
[29] Current trends in antiretroviral therapy for HIV infection and AIDS
Lertora, JJL
[J]. MEDICINA-BUENOS AIRES, 1999, 59 (05) : 533 - 534
[30] Immunosuppressive drugs and highly active Antiretroviral therapy: Pharmacokinetic interactions
Moretto, Johnny
Bessard, Germain
Stanke-Labesque, Francoise
[J]. THERAPIE, 2007, 62 (04): : 327 - 335

← 1 2 3 4 5 →